BENTSUR RON (CIK 1251213) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy NVCT (12,500 shares), Buy NVCT (150,000 shares), Buy NVCT (5,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Nuvectis Pharma, Inc. (NVCT) | Chairman & CEO | Buy | 12,500 | $250,000 |
| 2026-01-09 | Nuvectis Pharma, Inc. (NVCT) | Chairman & CEO | Buy | 150,000 | $0 |
| 2025-11-06 | Nuvectis Pharma, Inc. (NVCT) | Chairman & CEO | Buy | 5,000 | $28,600 |
Source: SEC Form 4 filings · as of 2026-07-01